TCM
AUGX

TD Capital Management’s Augmedix, Inc. Common Stock AUGX Stock Holding History

TD Capital Management’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,505
Closed -$2.35K – 419
2022
Q4 		$2.35K Hold
1,505
– – ﹤0.01% 329
2022
Q3 		$2K Buy
+1,505
New +$2.58K ﹤0.01% 328
2022
Q1 		– Sell
-1,505
Closed -$5K – 369
2021
Q4 		$5K Buy
+1,505
New +$5.46K ﹤0.01% 314

Other funds holding AUGX

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
SC
Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
TC
TownSquare Capital Provo, Utah $444M AUM 24.03% 1-Year Est. Return

TD Capital Management's AUGX Position: Q1 2023 in Review

TD Capital Management sold out of Augmedix, Inc. Common Stock (AUGX) in Q1 2023, closing a stake of 1,505 shares — an estimated $2.35K sold.

TD Capital Management first reported a position in AUGX in Q4 2021 and held it in 3 quarters. The position peaked at $5K in Q4 2021. 29 funds tracked by Wall St. Rank hold AUGX as of Q1 2023.

  • TD Capital Management reported no remaining Augmedix, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • TD Capital Management sold 1,505 Augmedix, Inc. Common Stock shares in Q1 2023, an estimated $2.35K.
  • TD Capital Management first reported a position in Augmedix, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • TD Capital Management's Augmedix, Inc. Common Stock position peaked at $5K in Q4 2021.
  • 29 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q1 2023.

Based on TD Capital Management's 13F filing for Q1 2023, filed 2 May 2023.